Guidant Champion Stent Design Flaw Delays Marketing By Up To Eight Months

A European launch of Guidant's Champion everolimus drug-eluting stent will require no additional clinical data, despite needed design and manufacturing changes, the firm says

More from Archive

More from Medtech Insight